Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
rivastigmine transdermal patch
Locations
75
United States
Orange, California, United States
San Francisco, California, United States
Boca Raton, Florida, United States
Fort Lauderdale, Florida, United States
Miami, Florida, United States
Miami Beach, Florida, United States
Start Date
November 1, 2003
Completion Date
January 1, 2006
Last Updated
October 13, 2017
NCT07033494
NCT06159673
NCT07457138
NCT07422857
NCT07214727
NCT06584357
Lead Sponsor
Novartis Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions